Search Results 2191-2200 of 16723 for Epilepsy (Partial Onset)

  1. A Study To Evaluate Efficacy Of Remibrutinib Compared To Dupilumab At Early Timepoints In Adults With Chronic Spontaneous Urticaria Inadequately Controlled By Second Generation H1-antihistamines - Mayo Clinic

    * CSU duration for ≥ 6 months prior to screening (defined as the onset of CSU determined by the Investigator based on all available supporting documentation) * ...

  2. Neurology - Clinical trials - Mayo Clinic

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

  3. Neurology - Clinical trials

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

  4. A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of pitolisant compared with placebo in treating excessive daytime sleepiness (EDS) in ...

  5. Study of Efficacy and Safety of CTL019 in Adult ALL Patients - Mayo Clinic

    The total duration of the primary follow-up is 1 year from cell infusion. ... Prothrombin Time (PT)/ Activated Partial Thromboplastin Time (aPTT) ≤ 1.5 x ULN at ...

  6. Medical Research & Education - Mayo Clinic News Network

    — You may have heard of the mind-body connection: the broad concept that thoughts and feelings, especially[...] Latest stories. Seizure forecasting with wrist- ...

  7. Medical Research & Education - Mayo Clinic News Network

    (VIDEO) When seizures don't stop: The battle against drug-resistant epilepsy. For Anthony Maita, 'Buddy' is not just any other dog.

  8. Medical Research & Education - Mayo Clinic News Network

    (VIDEO) When seizures don't stop: The battle against drug-resistant epilepsy. For Anthony Maita, 'Buddy' is not just any other dog.

  9. Neurology - Clinical trials - Mayo Clinic

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

  10. Funding - Aspirin-Exacerbated Respiratory Disease: Elina Jerschow - Mayo Clinic Research

    Investigator & Role, Grant Title, Funding Source, Duration. Elina Jerschow, M.D., M.S., principal investigator; Douglas G. Brownfield, Ph.D., co-principal ...